Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs

Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs

Background. The use of the bone-seeking properties of bisphosphonates (BPs) to target the delivery of therapeutic drugs is a promising approach for the treatment of bone metastases. Currently, the most advanced example of this approach is a gemcitabine-ibandronate conjugate (GEM-IB), where the bone-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jost Klawitter, Mckay Easton, Alexander Karpeisky, Kristen B. Farrell, Douglas H. Thamm, Touraj Shokati, Uwe Christians, Shawn Patrick Zinnen
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Molecules
Subjects:	bisphosphonates bone cancer pharmacokinetics gemcitabine ibandronate high-performance liquid chromatography mass spectrometry
Online Access:	https://www.mdpi.com/1420-3049/30/2/354
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01)

Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
by: MENG Zihe, et al.
Published: (2025-01-01)

An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
by: REN Jiaqiang, et al.
Published: (2024-12-01)

Therapeutic potential of bisphosphonates - review of medical indications, mechanism of action, interactions and adverse effects
by: Agnieszka Mikosińska, et al.
Published: (2025-01-01)

Enhanced expression of ten‐eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P‐glycoprotein expression
by: Chuanxu Wang, et al.
Published: (2019-03-01)

Solubility of gemcitabine (an anticancer drug) in supercritical carbon dioxide green solvent: Experimental measurement and thermodynamic modeling
by: Gholamhossein Sodeifian, et al.
Published: (2025-02-01)

Epithelial–Mesenchymal Transition Suppression by ML210 Enhances Gemcitabine Anti-Tumor Effects on PDAC Cells
by: Keisuke Takemura, et al.
Published: (2025-01-01)

Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
by: Yangyang Gao, et al.
Published: (2025-01-01)

Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4
by: Rongyu Shi, et al.
Published: (2025-02-01)

Exploring the potential of gemcitabine-metal–organic frameworks in combating pancreatic cancer under ketogenic conditions
by: Samira Nekoufar, et al.
Published: (2025-01-01)

A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic cancer therapy efficiency
by: Yuman Dong, et al.
Published: (2025-02-01)

Influence of Bisphosphonates on Alveolar Bone Loss around Osseointegrated Implants
by: Vivek, et al.
Published: (2024-12-01)

PI3Kδ inhibitor linperlisib combined with gemcitabine and oxaliplatin for relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase Ib/II trial
by: Peng Sun, et al.
Published: (2025-02-01)

Pharmacokinetic Evaluation of Neutral Sphinghomyelinase2 (nSMase2) Inhibitor Prodrugs in Mice and Dogs
by: Arina Ranjit, et al.
Published: (2024-12-01)

Effect of bisphosphonate on bone microstructure, mechanical strength in osteoporotic rats by ovariectomy
by: Yuzhu Wang, et al.
Published: (2024-09-01)

Teriparatidin ilaçlarla ilişkili çene osteonekrozu tedavisindeki etkinliği: hayvan çalışması
by: Cihan Topan, et al.
Published: (2020-08-01)

Biological Properties, Bioactive Constituents, and Pharmacokinetics of Some Capsicum spp. and Capsaicinoids
by: Gaber, El-Saber Batiha, et al.
Published: (2023)

Pharmacokinetics of difloxacin after single intravenous, oral and intramuscular administration in pigeons
by: Yang-Guang Jin, et al.
Published: (2025-02-01)

Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs
by: Sara Peribañez-Dominguez, et al.
Published: (2025-01-01)

A comprehensive review on the plant sources, pharmacological activities and pharmacokinetic characteristics of Syringaresinol
by: Lei Zhang, et al.
Published: (2025-02-01)

Bergenin, a bioactive flavonoid: advancements in the prospects of anticancer mechanism, pharmacokinetics and nanoformulations
by: Pratibha Pandey, et al.
Published: (2025-01-01)

Analysis of HIV therapy in the liver using optimal control and pharmacokinetics
by: Hasifa Nampala, et al.
Published: (2025-01-01)

Population Pharmacokinetic of Epidural Sufentanil in Labouring Women: A Multicentric, Prospective, Observational Study
by: Nie Y, et al.
Published: (2025-02-01)

Pharmacokinetics of Maternal Drug Administration: Insights into Placental Transfer and Fetal Exposure
by: Abdullah Duhaim, et al.
Published: (2024-12-01)

Pharmacokinetic comparisons of S-oxiracetam and R-oxiracetam in beagle dogs
by: Wang Wusan, et al.
Published: (2016-06-01)

Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White Adults
by: Ramesh R. Boinpally, et al.
Published: (2025-01-01)

Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
by: Fibi K. Ninan, et al.
Published: (2025-01-01)

The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
by: Filip Michalak, et al.
Published: (2025-01-01)

Pharmacokinetic evaluation of the interaction between oral kaempferol and ethanol in rats
by: Zhou Zhaoxiang, et al.
Published: (2016-12-01)

Etodolac Single Dose Metabolic Profile Elucidation: Pharmacokinetics and Adverse Events in Healthy Volunteers
by: Karen Sánchez-Luquez, et al.
Published: (2025-01-01)

Unlocking the potential of Rosmarinic acid: A review on extraction, isolation, quantification, pharmacokinetics and pharmacology
by: Haritha Harindranath, et al.
Published: (2025-02-01)

Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics
by: Li Ting-Ting, et al.
Published: (2015-06-01)

The Clinical Pharmacokinetics and Pharmacodynamics of Glimepiride—A Systematic Review and Meta-Analysis
by: Mubara Azhar, et al.
Published: (2025-01-01)

Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects
by: Tian M, et al.
Published: (2025-01-01)

Dissolution and Pharmacokinetic Studies of Paracetamol-4,4′-Bipyridine Cocrystals Obtained Using Four Methods
by: Xiaoming Zhang, et al.
Published: (2025-01-01)

Pharmacokinetics and pharmacodynamics of ciprofol after continuous infusion in elderly patients
by: Xiaowen Guo, et al.
Published: (2025-01-01)

Whole-Body Physiologically Based Pharmacokinetic Modeling of GalNAc-Conjugated siRNAs
by: Emilie Langeskov Salim, et al.
Published: (2025-01-01)

QbD-Driven preparation, characterization, and pharmacokinetic investigation of daidzein-l oaded nano-cargos of hydroxyapatite
by: Namrata Gautam, et al.
Published: (2025-01-01)

The molecular mechanism of gemcitabine in inhibiting the HIF-1α/VEGFB/FGF2/FGFR1 signaling pathway for ovarian cancer treatment
by: Liangliang Wang, et al.
Published: (2025-01-01)

Pharmacokinetic Analysis of an Isoniazid Suspension Among Spanish Children Under 6 Years of Age
by: Antoni Noguera-Julian, et al.
Published: (2025-01-01)